IDEHALER® allow to deliver an inhalable mass up to 90%,
in comparison with jet nebulizers or mesh nebulizers alone, which deliver an inhalable mass of 25% to 26%.
- Four-fold more drug into the lungs (vs. standard nebulizers).
- A 4µm of particle size aerosol for a lower airway delivery.
IDEHALER®.pdf
Scientific communication
! NEW ! Aerosolized gemcitabine in Patients with carcinoma of the lung: feasibility and safety study. Lemarie E., Vecellio L., Hureaux J., Prunier C., Valat C., Grimbert D., Boidron-Celle M., Giraudeau B., Le Pape A., Pichon E., Diot P., El Houfia A. and Gagnadoux F. J. Aerosol Med and Pulmonary Drug Delivery, 2011, 24 (6):261-270. Pubmed abstract
New aerosol delivery devices for cystic fibrosis. Kesser KC. and Geller DE. Respiratory Care, 2009, 54 (6):754-766. Pubmed abstract
In vitro/in vivo comparison of inhaled aerosol from a hand-held nebulizer for administration of amikacin. Fink J., Kadrichu N., Gribben D., Corkery K. ISAM, 2007.
In vitro/in vivo performances of the Idehaler® holding chamber operating with Aeroneb®Pro. Vecellio L., Colombier L., Diot P., Le Guellec S., Chantrel G. ISAM, 2007. Poster PDF file
In vitro study of a new nebulization system synchronized with patient expiration. Colombier L., Grimbert D., Diot P., Le Guellec S., Chantrel G., Vecellio L. DDL, 2006. Poster PDF file
In vivo justification of a physiological inspiratory/expiratory ratio to predict déposition of a novel valved spacer for liquid aerosol. Coates A., Fink J., Chantrel G., Diot P., Vecellio L. ATS, 2006. Poster PDF file
Factors influencing aerosolized albuterol delivery to the lower respiratory tract during non-invasive positive pressure ventilation. Mercier E., Waldrep JC., Grueber R., Dhand R. ATS, 2006. Poster PDF file
High doses of nebulized Amikacin during non-invasive positive pressure ventilation in healthy volunteers: pharmacokinetic and safety. Mercier E., Erhmann S., Vecellio L., Tenant D., Paintaud G., Dequin PF. ATS, 2006. Poster PDF file
In vitro evaluation of a novel inhalation chamber for nebulizers and MDI (Idehaler®). Vecellio L., Chantrel G., Diot P. ISAM, 2005. Poster PDF file